Clinical Trials

Nuralyte photonic analgesia/anesthesia device has been successfully tested in five in-human clinical trials demonstrating efficacy and safety

  • In the first three randomised single blinded clinical trials, Nuralyte has been able to significantly raise the electric pulp testing (EPT) threshold into levels sufficient to induce pre-emptive analgesia (anesthesia) when compared to three control diode laser devices.

  • In the fourth and fifth clinical trials, Nuralyte was significantly superior to topical aesthetic gel in eliminating or reducing the pain associated with dental needle injection.

  • After 60 seconds of exposure to the rays of Nuralyte, pre-emptive analgesia (anesthesia) was induced in human teeth in less than 2 minutes and lasted for around 20 minutes

  • The device is straightforward to use in dental settings and no particular training is required for dental staff